Skip to main content
. 2018 Jan 16;36(7):633–641. doi: 10.1200/JCO.2017.75.3384

Fig A4.

Fig A4.

Proportion of durable clinical benefit (DCB) above or below the (A) 25th, (B) 50th, (C) 75th, and (D) 90th percentiles of tumor mutation burden. Percentages of DCB in each group are reported above each bar. Error bars show the SE of the percentage. NDB, no durable response.